S 664
NIH Reform Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Bill overview
This bill, the NIH Reform Act, proposes to restructure the National Institutes of Health (NIH) by creating three separate national research institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases. It aims to streamline research efforts by focusing each institute on a specific area of disease, and it transfers existing responsibilities and authorities from the current National Institute of Allergy and Infectious Diseases to these new entities. The bill also establishes terms for the directors of these new institutes.
Key provisions
- Creates three new NIH institutes: the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases.
- Renames the National Institute of Allergy and Infectious Diseases to the National Institute of Allergic Diseases.
- Establishes terms of 5 years for the directors of the new institutes, with potential for one additional term.
- Transfers existing authorities and programs from the National Institute of Allergy and Infectious Diseases to the new institutes.
- Redesigns and amends relevant sections of the Public Health Service Act to reflect the new institute structure.
- Requires the Director of the NIH to ensure an orderly transition of responsibilities.
- Updates references to the National Institute of Allergy and Infectious Diseases throughout existing laws.
- Designates the purpose of each new institute: allergic diseases, infectious diseases, and immunologic diseases.
Who is affected
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
119th CONGRESS — 1st Session
S. 664
IN THE SENATE OF THE UNITED STATES
A BILL
To replace the National Institute of Allergy and Infectious Diseases with 3 separate national research institutes.
This Act may be cited as the NIH Reform Act
.
Section 401 of the Public Health Service Act (42 U.S.C. 281) is amended—
in subsection (b)—
in paragraph (6), by striking Allergy and Infectious Diseases
and inserting Allergic Diseases
;
by redesignating paragraph (25) as paragraph (27); and
by inserting after paragraph (24) the following:
The National Institute of Infectious Diseases.
The National Institute of Immunologic Diseases.
in subsection (d)(1), by striking 27
and inserting 29
.
Section 405(a)(1) of the Public Health Service Act (42 U.S.C. 284(a)(1)) is amended—
by inserting , the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases
after National Cancer Institute
; and
by inserting by and with the advice and consent of the Senate,
after the President,
.
Section 405(a) of the Public Health Service Act (42 U.S.C. 284(a)) is amended by adding at the end the following:
The appointments by the President of the Director of the National Institute of Allergic Diseases, the Director of the National Institute of Infectious Diseases, and the Director of the National Institute of Immunologic Diseases shall be for terms of 5 years. Each such Director may be reappointed for not more than 1 additional term, in accordance paragraph (1).
Effective on the date of enactment of this Act, the position of Director of the National Institute of Allergy and Infectious Diseases is terminated, and the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, and the National Institute of Immunologic Diseases shall be overseen by the Director of the National Institutes of Health until such time as the directors of each such national institutes is appointed pursuant to section 405(a)(1) of the Public Health Service Act (42 U.S.C. 284(a)(1)), as amended by paragraph (1).
Subpart 6 of part C of title IV of the Public Health Service Act (42 U.S.C. 285f et seq.) is amended—
in the subpart heading, by striking Allergy and infectious diseases
and inserting Allergic Diseases
; and
in section 446—
by striking Allergy and Infectious Diseases
and inserting Allergic Diseases
; and
by striking allergic and immunologic diseases and disorders and infectious diseases, including tropical diseases
and inserting allergic diseases and disorders
.
Part C of title IV of the Public Health Service Act (42 U.S.C. 285 et seq.) is amended by adding at the end the following:
The general purpose of the National Institute of Infectious Diseases is the conduct and support of research, training, health information dissemination, and other programs with respect to infectious diseases, including tropical diseases.
Sections 447A and 447B of the Public Health Service Act (42 U.S.C. 285f–2; 285f–3) are—
redesignated as sections 464z–11 and 464z–12, respectively; and
transferred to appear after section 464z–10 of such Act, as added by subparagraph (A).
The Director of the National Institutes of Health shall take such steps as are necessary to provide for the orderly transition to the authority of the National Institute of Infectious Diseases established under section 464z–10 of the Public Health Service Act, as added by subparagraph (A), from any authority related to infectious diseases of the National Institute of Allergy and Infectious Diseases, as in effect on the day before the date of enactment of this Act.
Part C of title IV of the Public Health Service Act (42 U.S.C. 285 et seq.), as amended by paragraph (2), is further amended by adding at the end the following:
The general purpose of the National Institute of Immunologic Diseases is the conduct and support of research, training, health information dissemination, and other programs with respect to immunologic diseases and disorders.
Sections 447 and 447C of the Public Health Service Act (42 U.S.C. 285f–1; 285f–4) are—
redesignated as sections 464z–16 and 464z–17, respectively; and
transferred to appear after section 464z–15 of such Act, as added by subparagraph (A).
The Director of the National Institutes of Health shall take such steps as are necessary to provide for the orderly transition to the authority of the National Institute of Immunologic Diseases established under section 464z–15 of the Public Health Service Act, as added by subparagraph (A), from any authority related to immunologic diseases and disorders of the National Institute of Allergy and Infectious Diseases, as in effect on the day before the date of enactment of this Act.
Section 404B of the Public Health Service Act (42 U.S.C. 283d) is amended by striking National Institute for Allergy and Infectious Diseases
and inserting National Institute for Infectious Diseases
.
Section 404I of the Public Health Service Act (42 U.S.C. 283k) is amended—
in subsection (a)(1), by striking or the Director of the National Institute for Allergy and Infectious Diseases
; and
by striking or the National Institute for Allergy and Infectious Diseases
each place it appears.
Section 442A(a) of the Public Health Service Act (42 U.S.C. 285d–8(a)) is amended by striking Allergy and Infectious Diseases
and inserting Immunologic Diseases
.
Any reference in any law (including a regulation), guidance, map, document, record, or other paper of the United States to the National Institute of Allergy and Infectious Diseases, including with respect to the Director of such Institute, shall be deemed to be a reference to, as applicable, the National Institute of Allergic Diseases, the National Institute of Infectious Diseases, or the National Institute of Immunologic Diseases, including with respect to the Directors of such Institutes.